#Calithera Biosciences (CALA)

Improving on immunotherapy and preventing one of its serious side effects

The Week in Review #34 Improving on Immunotherapy and preventing one of its serious side effects. Removal of glutamine leads to a substantial reduction in cell growth or induces cell death in certain...

P

Prohost Biotech

Nov 13, 2018

The molecule that enhanced the T Cells cancer treatment efficacy while preventing autoimmune diseases

Yesterday, the Stock Market skyrocketed and with it a significant number of Prohost Picks that we keep reminding ourselves are undervalued. The outperformance unveiled the interred strength of firms s...

P

Prohost Biotech

Nov 8, 2018

Incyte: A Thoughtful Research and Collaboration Agreement with Abramson Cancer Center

Incyte Announces a Multi-year Research Collaboration with the Abramson Cancer Center at the University of Pennsylvania . The aim of the agreement with Abramson Cancer Center at the University of Penns...

P

Prohost Biotech

Feb 24, 2017

Incyte and Calithera Collaboration Is Fair and Lucrative for Both Firms

Incyte and Calithera Biosciences Announce Global Collaboration to Develop and Commercialize CB-1158, a Small Molecule Arginase Inhibitor Incyte (INCY) and Calithera Bioscience...

P

Prohost Biotech

Jan 30, 2017

Calithera Moving Forward

Calithera Biosciences, (CALA) discovers and develops small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer . Calithera’s lead product candidat...

P

Prohost Biotech

Nov 6, 2015

Refreshing Investors Memory and the Best of the Best Technologies and Firms

We don’t know whether we can say good morning to the world at a morning when Paris has fallen victim of a terrorist attack that killed 12 innocent humans. All we can do is pray for a miracle that can...

P

Prohost Biotech

Jan 7, 2015

Monday, January 5, 2015: Outperforming and Positive Performing Picks

OUR OUTPERFORMING PICKS ON MONDAY 5/1/2015 ISIS: Closed at $68.17 UP $6.60 J&J is licensing three programs for autoimmune diseases from Isi...

P

Prohost Biotech

Jan 6, 2015

Prohost Letter #374

...

P

Prohost Biotech

Dec 26, 2014

Calithera (CALA) Designed and Is Testing Very Interesting Small Molecule Cancer Drugs

A lone wolf managed to turn yesterday’s morning feast into a nightmare. Lives were stolen away from innocent seekers of happiness in the season of happiness. The feeling of fear and bad prospects shou...

P

Prohost Biotech

Dec 16, 2014

1m

0